Positron emission tomography : clinical practice /

The use of positron emission tomography (PET) in clinical practice is key to the s- cessful management of many patients with a wide variety of diseases. Whereas in the 1980s and 1990s nuclear medicine physicians struggled to convince other doctors about the potential clinical value of PET, it is now...

Full description

Saved in:
Bibliographic Details
Other Authors: Valk, Peter E 1940-
Format: Book
Language:English
Published: London Springer c2006
©2006
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-341099
005 2024429105720
008 240529t20062006ENK a# #001 eng D
020 # # |a 1852339713  |q hardback 
020 # # |a 9781852339715  |q hardback 
040 # # |a UKM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a WN 206 
090 0 0 |a WN206  |b P8552 2006 
245 1 1 |a Positron emission tomography :  |b clinical practice /  |c [edited by] Peter E. Valk... [et al.] (eds) 
264 # 1 |a London  |b Springer  |c c2006 
264 # 1 |c ©2006 
300 # # |a xiv, 475 pages  |b illustration (some colour)  |c 29 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
500 # # |a Selected and updated version of: Positron emission tomography : basic science and clinical practice / Peter E. Valk ... [et al.], c2003 
504 # # |a Includes bibliographical references and index 
520 # # |a The use of positron emission tomography (PET) in clinical practice is key to the s- cessful management of many patients with a wide variety of diseases. Whereas in the 1980s and 1990s nuclear medicine physicians struggled to convince other doctors about the potential clinical value of PET, it is now a challenge to keep up with the requests of our clinical colleagues for the various applications of PET. In fact, in most cases the barriers are now related to reimbursement for a given PET procedure. At the time this foreword was written, many FDG/PET procedures are reimbursable, and the U.S. National PET Registry, which is about to be implemented, will allow FDG/PET imaging data to accumulate on rare tumors, while allowing for Center for Medicare and Medicaid Services (CMS) reimbursement. The challenges are now shifting toward solving some of the limitations of FDG/PET through the use of next generation inst- mentation and newer tracers that hold the promise of improving on what is already a remarkable achievement with FDG/PET. It is my hope that there will in fact be an enormous growth of nuclear medicine driven by new imaging tracers that will fuel a growing number of clinical applications. 
650 # 0 |a Tomography, Emission 
650 # 0 |a Clinical Medicine  |x methods 
650 # 0 |a Positron-Emission Tomography  |x methods 
700 1 # |a Valk, Peter E  |d 1940- 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=341099 
964 # # |c BOK  |d 01 
998 # # |a 00250##a006.2.2||00250##b006.2.2||00255##a006.2.2||00260##a006.2.2||00260##b006.2.2||00260##c006.2.2||00264#1a006.2.2||00264#1b006.2.2||01264#1a006.2.2||01264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00500##a006.2.2||00502##a006.2.2||00520##a006.2.2||00520##b006.2.2||00538##a006.2.2||00546##a006.2.2||00730##a006.2.2||00730##d006.4||00730##f006.10||00730##n006.2.2||00730##p006.2.2||